- Home
- MET vs KVUE Comparison
MET vs KVUE Comparison
Compare MET & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MET
- KVUE
- Stock Information
- Founded
- MET 1863
- KVUE 2022
- Country
- MET United States
- KVUE United States
- Employees
- MET N/A
- KVUE N/A
- Industry
- MET Life Insurance
- KVUE Specialty Chemicals
- Sector
- MET Finance
- KVUE Consumer Discretionary
- Exchange
- MET Nasdaq
- KVUE Nasdaq
- Market Cap
- MET 49.7B
- KVUE 41.0B
- IPO Year
- MET N/A
- KVUE 2023
- Fundamental
- Price
- MET $81.49
- KVUE $21.62
- Analyst Decision
- MET Strong Buy
- KVUE Buy
- Analyst Count
- MET 10
- KVUE 12
- Target Price
- MET $95.60
- KVUE $24.38
- AVG Volume (30 Days)
- MET 3.6M
- KVUE 18.4M
- Earning Date
- MET 08-06-2025
- KVUE 08-07-2025
- Dividend Yield
- MET 2.79%
- KVUE 3.79%
- EPS Growth
- MET 61.27
- KVUE 28.77
- EPS
- MET 5.93
- KVUE 0.74
- Revenue
- MET $73,011,000,000.00
- KVUE $15,141,000,000.00
- Revenue This Year
- MET $7.25
- KVUE $2.34
- Revenue Next Year
- MET $3.69
- KVUE $3.56
- P/E Ratio
- MET $13.75
- KVUE $29.20
- Revenue Growth
- MET 6.17
- KVUE N/A
- 52 Week Low
- MET $65.21
- KVUE $19.75
- 52 Week High
- MET $89.05
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- MET 65.45
- KVUE 50.06
- Support Level
- MET $78.46
- KVUE $21.35
- Resistance Level
- MET $78.33
- KVUE $21.85
- Average True Range (ATR)
- MET 1.55
- KVUE 0.53
- MACD
- MET 0.61
- KVUE 0.00
- Stochastic Oscillator
- MET 95.72
- KVUE 56.63
About MET MetLife Inc.
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.